Back to
PRIMECAP MANAGEMENT CO/CA/
GSK16 quarters
Position history for
PRIMECAP MANAGEMENT CO/CA/'s holdings in GSK PLC
Yes. Primecap holds 25,182,068 shares of GSK, worth $1.3B, as of its Q2 2026 13F filing. It reduced the position by 22,470 shares (-0.1%) from Q1 2026. Primecap has held GSK in every 13F on record since Q3 2022, 16 quarterly filings. GSK is 0.8% of Primecap's reported 13F portfolio.
Current Value
$1.3B
Current Shares
25.2M
Total Value Change
+$1.3B
Total Shares Change
+24.7M
Quarter-by-Quarter History
Other major holders of GSK: FMR LLC, DODGE & COX